ΔNp63-restricted viral mimicry response impedes cancer cell viability and remodels tumor microenvironment in esophageal squamous cell carcinoma
Authors:
Preprint
Abstract
Tumor protein p63 isoform ΔNp63 plays roles in the squamous epithelium and squamous cell carcinomas (SCCs), including esophageal SCC (ESCC). By integrating data from cell lines and our latest patient-derived organoid cultures, derived xenograft models, and clinical sample transcriptomic analyses, we identified a novel and robust oncogenic role of ΔNp63 in ESCC. We showed that ΔNp63 maintains the repression of cancer cell endogenous retrotransposon expression and cellular double-stranded RNA sensing. These subsequently lead to a restricted cancer cell viral mimicry response and suppressed induction of tumor-suppressive type I interferon (IFN-I) signaling through the regulations of Signal transducer and activator of transcription 1, Interferon regulatory factor 1, and cGAS-STING pathway. The cancer cell ΔNp63-IFN-I signaling axis affects both the cancer cell and tumor-infiltrating immune cell (TIIC) compartments. In cancer cells, depletion of ΔNp63 resulted in reduced cell viability. ΔNp63 expression is negatively associated with the anticancer responses to viral mimicry booster treatments targeting cancer cells. In the tumor microenvironment, cancer cell TP63 expression negatively correlates with multiple TIIC signatures in ESCC clinical samples. ΔNp63 depletion leads to increased cancer cell antigen presentation molecule expression and enhanced recruitment and reprogramming of tumor-infiltrating myeloid cells. Similar IFN-I signaling and TIIC signature association with ΔNp63 were also observed in lung SCC. These results support the potential application of ΔNp63 as a therapeutic target and a biomarker to guide candidate anticancer treatments exploring viral mimicry responses.Keywords
All Related Versions
- Published version: Cancer Letters, 595, 216999.
This publication has 69 references indexed in Scilit:
- Myeloid-Derived Suppressor Cells in the Tumor Microenvironment2020
- Endoplasmic reticulum-localized ECM1b suppresses tumor growth and regulates MYC and MTORC1 through modulating MTORC2 activation in esophageal squamous cell carcinomaCancer Letters, 2019
- ΔNp63 in squamous cell carcinoma: defining the oncogenic routes affecting epigenetic landscape and tumour microenvironmentMolecular Oncology, 2019
- Profiling Tumor Infiltrating Immune Cells with CIBERSORT2018
- Whole‐exome sequencing reveals critical genes underlying metastasis in oesophageal squamous cell carcinomaThe Journal of Pathology, 2017
- Tumor-induced perturbations of cytokines and immune cell networksBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2014
- Comparative Genomics of Esophageal Adenocarcinoma and Squamous Cell CarcinomaThe Annals of Thoracic Surgery, 2012
- Genetic alterations in a telomerase-immortalized human esophageal epithelial cell line: Implications for carcinogenesisCancer Letters, 2010
- Cytogenetic aberrations in immortalization of esophageal epithelial cellsCancer Genetics and Cytogenetics, 2006
- Elevated expression of p63 protein in human esophageal squamous cell carcinomasInternational Journal of Cancer, 2002